Monitor the outcome of David B. Roberts' election at the 2026 Annual Meeting and assess any potential shifts in board dynamics, though no material governance concerns are indicated.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Apr 14 $117.39entry
- T+1 · 7mo ago −2.20%α −2.97% · $114.81
- T+5 · 7mo ago −4.68%α −6.07% · $111.90
- T+20 · 6mo ago −13.42%α −19.71% · $101.64
- T+60 · 4mo ago −12.77%α −21.29% · $102.40
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
LeMaitre Vascular announced director Bridget Ross will not stand for re-election at the 2026 Annual Meeting, and the board nominated David B. Roberts to fill the Class II seat. Concurrently, the company reduced its board size from eight to seven members effective upon Ross's departure. These changes are part of a board rebalancing effort with no indication of operational disagreements.
Key Facts
- Director Bridget Ross notified the board on April 8, 2026, of her decision not to stand for re-election at the 2026 Annual Meeting.
- David B. Roberts was nominated to stand for election as a Class II director, contingent on his conditional resignation as a Class I director.
- The board size is being reduced from eight to seven members effective upon Ross's departure.
- The company stated Ross's decision is not related to any disagreement with the company.
Financial Impact
No direct financial impact disclosed
Risk Factors
- Potential for minor governance disruption during transition
- Uncertainty around Roberts' qualifications and future board balance
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-153779 |
| Document: 0001193125-26-153779-index-headers.html | 0001193125-26-153779 |
| Document: 0001193125-26-153779-index.html | 0001193125-26-153779 |
| Document: 0001193125-26-153779.txt | 0001193125-26-153779 |
Track record
14 reports on LMAT
3 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +15.08% at T+20 after the May 7, 2026 report. 3 of 5 went positive at some point.
Filters
- Nov 4, 202612d ago 8-K Bearish 6/10 Entry $83.49 to $77.65 Now $77.01 +7.76% ▲ +6.99% +10.29% vs SPY
- Nov 2, 202614d ago Institutional Cluster Neutral 3/10 Entry $80.60 to $79.02 Now $77.01 −4.45% ▼ −1.96% −1.37% vs SPY
- Oct 15, 20264w ago 8-K Neutral 2/10 Entry $80.82 to $84.45 Now $77.01 −4.71% ▲ +4.49% +4.40% vs SPY
- Aug 27, 202611w ago Press Release Neutral 2/10 Entry $80.45 to $80.67 Now $77.01 −4.28% ▲ +0.27% +0.16% vs SPY
- Jul 14, 202617w ago Press Release Neutral 1/10 Entry $99.79 Now $77.01 −22.83% No price data
- May 7, 202627w ago Insider Cluster Bearish 4/10 Entry $107.91 to $98.17 Now $77.01 +28.63% ▲ +9.03% +10.53% vs SPY
- May 7, 202627w ago Insider Cluster Neutral 2/10 Entry $107.91 to $98.17 Now $77.01 −28.63% ▼ −9.03% −10.53% vs SPY
- May 7, 202627w ago Insider Cluster Neutral 3/10 Entry $107.91 to $98.17 Now $77.01 −28.63% ▼ −9.03% −10.53% vs SPY
- May 5, 202627w ago 8-K Bullish 7/10 Entry $110.22 to $97.22 Now $77.01 −30.13% ▼ −11.79% −12.93% vs SPY
- Apr 14, 202630w ago DEFA14A Neutral 3/10 Entry $117.39 to $111.90 Now $77.01 −34.40% ▼ −4.68% −6.07% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers